Literature DB >> 24900392

"It Ain't Over 'til It's Over" (a) -The Search for Treatments and Cures for Alzheimer's Disease.

Richard J Hargreaves1.   

Abstract

In the neuroscience landscape, there is no condition with higher unmet medical and societal need than Alzheimer's disease (AD). There are significant opportunities to improve upon symptomatic treatments in AD, and as yet, there are no treatments to modify (slow, stop, or prevent) underlying disease progression. Our goals are to discover new symptomatic AD therapies with improved efficacy and longevity; to complete definitive studies that refute or prove the amyloid hypothesis, potentially opening multiple avenues to new therapeutic modalities; and to initiate tests of novel mechanisms that can prevent tau pathology and neurodegeneration. It's a critical time in the testing of novel AD therapeutics-let's hope we succeed.

Entities:  

Year:  2012        PMID: 24900392      PMCID: PMC4025775          DOI: 10.1021/ml300359g

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  9 in total

Review 1.  The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Enchi Liu; John C Morris; Ronald C Petersen; Andrew J Saykin; Mark E Schmidt; Leslie Shaw; Judith A Siuciak; Holly Soares; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2011-11-02       Impact factor: 21.566

Review 2.  Clinical practice. Early Alzheimer's disease.

Authors:  Richard Mayeux
Journal:  N Engl J Med       Date:  2010-06-10       Impact factor: 91.245

Review 3.  The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics.

Authors:  Eric Karran; Marc Mercken; Bart De Strooper
Journal:  Nat Rev Drug Discov       Date:  2011-08-19       Impact factor: 84.694

4.  Preventing Alzheimer's disease.

Authors:  Dennis J Selkoe
Journal:  Science       Date:  2012-09-21       Impact factor: 47.728

5.  A mutation in APP protects against Alzheimer's disease and age-related cognitive decline.

Authors:  Thorlakur Jonsson; Jasvinder K Atwal; Stacy Steinberg; Jon Snaedal; Palmi V Jonsson; Sigurbjorn Bjornsson; Hreinn Stefansson; Patrick Sulem; Daniel Gudbjartsson; Janice Maloney; Kwame Hoyte; Amy Gustafson; Yichin Liu; Yanmei Lu; Tushar Bhangale; Robert R Graham; Johanna Huttenlocher; Gyda Bjornsdottir; Ole A Andreassen; Erik G Jönsson; Aarno Palotie; Timothy W Behrens; Olafur T Magnusson; Augustine Kong; Unnur Thorsteinsdottir; Ryan J Watts; Kari Stefansson
Journal:  Nature       Date:  2012-08-02       Impact factor: 49.962

6.  The β-Amyloid Hypothesis in Alzheimer's Disease: Seeing Is Believing.

Authors:  Hank F Kung
Journal:  ACS Med Chem Lett       Date:  2012-03-12       Impact factor: 4.345

Review 7.  Biochemistry and cell biology of tau protein in neurofibrillary degeneration.

Authors:  Eva-Maria Mandelkow; Eckhard Mandelkow
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

Review 8.  The secretases: enzymes with therapeutic potential in Alzheimer disease.

Authors:  Bart De Strooper; Robert Vassar; Todd Golde
Journal:  Nat Rev Neurol       Date:  2010-02       Impact factor: 42.937

9.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.

Authors:  Clifford R Jack; David S Knopman; William J Jagust; Leslie M Shaw; Paul S Aisen; Michael W Weiner; Ronald C Petersen; John Q Trojanowski
Journal:  Lancet Neurol       Date:  2010-01       Impact factor: 44.182

  9 in total
  1 in total

1.  Glycogen Synthase Kinase 3β: A New Gold Rush in Anti-Alzheimer's Disease Multitarget Drug Discovery?

Authors:  Angela De Simone; Vincenzo Tumiatti; Vincenza Andrisano; Andrea Milelli
Journal:  J Med Chem       Date:  2020-12-21       Impact factor: 7.446

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.